Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danner

Showing results (1181-1190 of 1,521) with videos related to

Pageof 153
Sort By:
AIDS (London, England)|December 20, 2003
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimenSanjay U C Sankatsing, Gerrit J Weverling, Monika Peeters, et al.
AIDS (London, England)|February 1, 1988
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudineJ de Gans, J M Lange, M M Derix, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2022
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based ChemotherapySunyoung Lee, Rachna T Shroff, Shalini Makawita, et al.
Journal of the American College of Cardiology|October 26, 2010
Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5Manling Zhang, Eiki Takimoto, Steven Hsu, et al.
AIDS (London, England)|April 20, 1999
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogsJ J de Jong, J Goudsmit, V V Lukashov, et al.
AIDS (London, England)|December 22, 2007
Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapyRegje Me Blümer, Marit Ga van Vonderen, Jussi Sutinen, et al.
Oncotarget|July 8, 2016
CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cellsNadja Zaborsky, Franz Josef Gassner, Daniela Asslaber, et al.
AIDS (London, England)|October 21, 2003
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patientsMarchina E van der Ende, Jan M Prins, Kees Brinkman, et al.
Blood|June 17, 2008
Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantationCharles G Mullighan, Susan L Heatley, Silke Danner, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agentsN G Pakker, M T Roos, R van Leeuwen, et al.
Pageof 153

Showing results (1181-1190 of 1,521) with videos related to

Sort By:
Pageof 153
AIDS (London, England)|December 20, 2003
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimenSanjay U C Sankatsing, Gerrit J Weverling, Monika Peeters, et al.
AIDS (London, England)|February 1, 1988
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudineJ de Gans, J M Lange, M M Derix, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2022
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based ChemotherapySunyoung Lee, Rachna T Shroff, Shalini Makawita, et al.
Journal of the American College of Cardiology|October 26, 2010
Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5Manling Zhang, Eiki Takimoto, Steven Hsu, et al.
AIDS (London, England)|April 20, 1999
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogsJ J de Jong, J Goudsmit, V V Lukashov, et al.
AIDS (London, England)|December 22, 2007
Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapyRegje Me Blümer, Marit Ga van Vonderen, Jussi Sutinen, et al.
Oncotarget|July 8, 2016
CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cellsNadja Zaborsky, Franz Josef Gassner, Daniela Asslaber, et al.
AIDS (London, England)|October 21, 2003
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patientsMarchina E van der Ende, Jan M Prins, Kees Brinkman, et al.
Blood|June 17, 2008
Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantationCharles G Mullighan, Susan L Heatley, Silke Danner, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agentsN G Pakker, M T Roos, R van Leeuwen, et al.
Pageof 153